Related Experiment Video
Updated: Sep 21, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
Blocking Mitochondrial Zn2+ Accumulation after Ischemia Reduces Mitochondrial Dysfunction and Neuronal Injury
Yuliya V Medvedeva1, Hong Z Yin1, Afsheen Bazrafkan1
1Departments of Neurology.
Abstract:
Zn2+ is an important contributor to ischemic brain injury, and recent studies support the hypothesis that mitochondria are key sites of its injurious effects. In murine hippocampal slices (both sexes) subjected to oxygen glucose deprivation (OGD), we found that Zn2+ accumulation and its entry into mitochondria precedes and contributes to the induction of acute neuronal death. In addition, if the ischemic episode is short (and sublethal), there is ongoing Zn2+ accumulation in CA1 mitochondria after OGD that may contribute to their delayed dysfunction. Using this slice model of sublethal OGD, we have examined Zn2+ contributions to the progression of changes evoked by OGD and occurring over 4-5 h. We detected progressive mitochondrial depolarization occurring from ∼2 h after ischemia, a large increase in spontaneous synaptic activity between 2 and 3 h, and mitochondrial swelling and fragmentation at 4 h. Blockade of the primary route for Zn2+ entry, the mitochondrial Ca2+ uniporter (with ruthenium red [RR]) or Zn2+ chelation shortly after OGD withdrawal substantially attenuated the mitochondrial depolarization and the changes in synaptic activity. RR also largely reversed the mitochondrial swelling. Finally, using an in vivo rat (male) asphyxial cardiac arrest model of transient global ischemia, we found that ∼8 min asphyxia induces considerable injury of CA1 neurons 4 h later that is associated with strong Zn2+ accumulation within many damaged mitochondria. These effects were substantially attenuated by infusion of RR on reperfusion. Our findings highlight mitochondrial Zn2+ accumulation after ischemia as a possible target for neuroprotective therapy.SIGNIFICANCE STATEMENT Brain ischemia is a leading cause of mortality and long-term disability that still lacks effective treatment. After transient ischemia, delayed death of neurons occurs in vulnerable brain regions. There is a critical need to understand mechanisms of this delayed neurodegeneration which can be targeted for neuroprotection. We found progressive and long-lasting mitochondrial Zn2+ accumulation to occur in highly vulnerable CA1 neurons after ischemia. Here we demonstrate that this Zn2+ accumulation contributes strongly to deleterious events occurring after ischemia, including mitochondrial dysfunction, swelling, and structural changes. We suggest that this mitochondrial Zn2+ entry may constitute a promising target for development of therapeutic interventions to be delivered after termination of an episode of transient global ischemia.
Insights
Mitochondrial zinc accumulation contributes to brain injury after ischemia. Blocking zinc entry into mitochondria with ruthenium red attenuated neuronal death and dysfunction in animal models.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Ischemic brain injury is a major cause of death and disability.
- Delayed neuronal death in vulnerable brain regions after transient ischemia requires mechanistic understanding for neuroprotection.
- Mitochondria are implicated as key sites of zinc's injurious effects in the brain.
Purpose of the Study:
- To investigate the role of zinc (Zn2+) accumulation in mitochondria during and after ischemic conditions.
- To determine if targeting mitochondrial zinc entry can offer neuroprotection against ischemic brain injury.
- To elucidate the contribution of mitochondrial zinc to delayed neuronal dysfunction and death post-ischemia.
Main Methods:
- Oxygen-glucose deprivation (OGD) in murine hippocampal slices (both sexes).
- Assessment of mitochondrial function (depolarization, swelling, fragmentation) and synaptic activity.
- Pharmacological inhibition of mitochondrial zinc entry using ruthenium red (RR) or zinc chelation.
- In vivo rat model (male) of transient global ischemia induced by asphyxial cardiac arrest.
Main Results:
- Zn2+ accumulated in mitochondria during OGD, preceding and contributing to acute neuronal death.
- Sublethal OGD led to progressive mitochondrial depolarization, increased synaptic activity, and mitochondrial structural changes (swelling, fragmentation).
- Ruthenium red or zinc chelation post-OGD attenuated mitochondrial dysfunction and synaptic changes, with RR reversing swelling.
- In vivo, RR infusion post-ischemia reduced CA1 neuronal injury associated with mitochondrial Zn2+ accumulation.
Conclusions:
- Mitochondrial Zn2+ accumulation is a significant contributor to neuronal damage and dysfunction following ischemic events.
- Targeting mitochondrial zinc entry, for example with ruthenium red, shows promise as a neuroprotective strategy after transient global ischemia.
- Interventions aimed at reducing mitochondrial zinc post-ischemia could offer a therapeutic approach for treating ischemic brain injury.

